Association of TLR4-T399I Polymorphism with Chronic Obstructive Pulmonary Disease in Smokers

Tobacco smoking has been considered the most important risk factor for chronic obstructive pulmonary disease (COPD) development. However, not all smokers develop COPD and other environmental and genetic susceptibility factors underlie disease pathogenesis. Recent studies have indicated that the impa...

Full description

Saved in:
Bibliographic Details
Main Authors: Matthaios Speletas, Vassiliki Merentiti, Konstantinos Kostikas, Kyriaki Liadaki, Markos Minas, Konstantinos Gourgoulianis, Anastasios E. Germenis
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2009/260286
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550136181424128
author Matthaios Speletas
Vassiliki Merentiti
Konstantinos Kostikas
Kyriaki Liadaki
Markos Minas
Konstantinos Gourgoulianis
Anastasios E. Germenis
author_facet Matthaios Speletas
Vassiliki Merentiti
Konstantinos Kostikas
Kyriaki Liadaki
Markos Minas
Konstantinos Gourgoulianis
Anastasios E. Germenis
author_sort Matthaios Speletas
collection DOAJ
description Tobacco smoking has been considered the most important risk factor for chronic obstructive pulmonary disease (COPD) development. However, not all smokers develop COPD and other environmental and genetic susceptibility factors underlie disease pathogenesis. Recent studies have indicated that the impairment of TLR signaling might play a crucial role in the development of emphysema. For this purpose we investigated the prevalence and any possible associations of common TLR polymorphisms (𝑇𝐿𝑅2-R753Q, 𝑇𝐿𝑅4-D299G, and 𝑇𝐿𝑅4-T399I) in a group of 240 heavy smokers (>20 pack years), without overt atherosclerosis disease, of whom 136 had developed COPD and 104 had not. The presence of 𝑇𝐿𝑅4-T399I polymorphism was associated with a 2.4-fold increased risk for COPD development (𝑃=.044), but not with disease stage or frequency of exacerbations. Considering that infections contribute to COPD and emphysema pathogenesis, our findings possibly indicate that dysfunctional polymorphisms of innate immune genes can affect the development of COPD in smokers. Although this finding warrants further investigation, it highlights the importance of impaired innate immunity towards COPD development.
format Article
id doaj-art-4b6f4654716c4586a54015b474b9f5c4
institution Kabale University
issn 1740-2522
1740-2530
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-4b6f4654716c4586a54015b474b9f5c42025-02-03T06:07:35ZengWileyClinical and Developmental Immunology1740-25221740-25302009-01-01200910.1155/2009/260286260286Association of TLR4-T399I Polymorphism with Chronic Obstructive Pulmonary Disease in SmokersMatthaios Speletas0Vassiliki Merentiti1Konstantinos Kostikas2Kyriaki Liadaki3Markos Minas4Konstantinos Gourgoulianis5Anastasios E. Germenis6Department of Immunology and Histocompatibility, University of Thessaly Medical School, 41110 Larissa, GreeceDepartment of Immunology and Histocompatibility, University of Thessaly Medical School, 41110 Larissa, GreeceRespiratory Medicine Department, University of Thessaly Medical School, 41110 Larissa, GreeceDepartment of Immunology and Histocompatibility, University of Thessaly Medical School, 41110 Larissa, GreeceRespiratory Medicine Department, University of Thessaly Medical School, 41110 Larissa, GreeceRespiratory Medicine Department, University of Thessaly Medical School, 41110 Larissa, GreeceDepartment of Immunology and Histocompatibility, University of Thessaly Medical School, 41110 Larissa, GreeceTobacco smoking has been considered the most important risk factor for chronic obstructive pulmonary disease (COPD) development. However, not all smokers develop COPD and other environmental and genetic susceptibility factors underlie disease pathogenesis. Recent studies have indicated that the impairment of TLR signaling might play a crucial role in the development of emphysema. For this purpose we investigated the prevalence and any possible associations of common TLR polymorphisms (𝑇𝐿𝑅2-R753Q, 𝑇𝐿𝑅4-D299G, and 𝑇𝐿𝑅4-T399I) in a group of 240 heavy smokers (>20 pack years), without overt atherosclerosis disease, of whom 136 had developed COPD and 104 had not. The presence of 𝑇𝐿𝑅4-T399I polymorphism was associated with a 2.4-fold increased risk for COPD development (𝑃=.044), but not with disease stage or frequency of exacerbations. Considering that infections contribute to COPD and emphysema pathogenesis, our findings possibly indicate that dysfunctional polymorphisms of innate immune genes can affect the development of COPD in smokers. Although this finding warrants further investigation, it highlights the importance of impaired innate immunity towards COPD development.http://dx.doi.org/10.1155/2009/260286
spellingShingle Matthaios Speletas
Vassiliki Merentiti
Konstantinos Kostikas
Kyriaki Liadaki
Markos Minas
Konstantinos Gourgoulianis
Anastasios E. Germenis
Association of TLR4-T399I Polymorphism with Chronic Obstructive Pulmonary Disease in Smokers
Clinical and Developmental Immunology
title Association of TLR4-T399I Polymorphism with Chronic Obstructive Pulmonary Disease in Smokers
title_full Association of TLR4-T399I Polymorphism with Chronic Obstructive Pulmonary Disease in Smokers
title_fullStr Association of TLR4-T399I Polymorphism with Chronic Obstructive Pulmonary Disease in Smokers
title_full_unstemmed Association of TLR4-T399I Polymorphism with Chronic Obstructive Pulmonary Disease in Smokers
title_short Association of TLR4-T399I Polymorphism with Chronic Obstructive Pulmonary Disease in Smokers
title_sort association of tlr4 t399i polymorphism with chronic obstructive pulmonary disease in smokers
url http://dx.doi.org/10.1155/2009/260286
work_keys_str_mv AT matthaiosspeletas associationoftlr4t399ipolymorphismwithchronicobstructivepulmonarydiseaseinsmokers
AT vassilikimerentiti associationoftlr4t399ipolymorphismwithchronicobstructivepulmonarydiseaseinsmokers
AT konstantinoskostikas associationoftlr4t399ipolymorphismwithchronicobstructivepulmonarydiseaseinsmokers
AT kyriakiliadaki associationoftlr4t399ipolymorphismwithchronicobstructivepulmonarydiseaseinsmokers
AT markosminas associationoftlr4t399ipolymorphismwithchronicobstructivepulmonarydiseaseinsmokers
AT konstantinosgourgoulianis associationoftlr4t399ipolymorphismwithchronicobstructivepulmonarydiseaseinsmokers
AT anastasiosegermenis associationoftlr4t399ipolymorphismwithchronicobstructivepulmonarydiseaseinsmokers